Synergistic silencing: Combinations of lipid-like materials for efficacious siRNA delivery

Molecular Therapy

Volumn 19, Issue 9, 2011, Pages 1688-1694

  Whitehead, Kathryn A ^a   Sahay, Gaurav ^a   Li, George Z ^b   Love, Kevin T ^b   Alabi, Christopher A ^a   Ma, Minglin ^a   Zurenko, Christopher ^c   Querbes, William ^c   Langer, Robert S ^a,b   Anderson, Daniel G ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c ALNYLAM PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LUCIFERASE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; ENDOSOME; FEMALE; GENE INTERACTION; GENE SILENCING; GENETIC REGULATION; HELA CELL; HUMAN; HUMAN CELL; MICROSCOPY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; RNA INTERFERENCE; TARGET CELL;

MUS;

EID: 80052421854     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.141     Document Type: Article

References (27)

1. Fire, A, Xu, S, Montgomery, MK, Kostas, SA, Driver, SE and Mello, CC (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811 (Pubitemid 28099681)
2. Elbashir, SM, Harborth, J, Lendeckel, W, Yalcin, A, Weber, K and Tuschl, T (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498 (Pubitemid 32494397)
3. Geisbert, TW, Lee, AC, Robbins, M, Geisbert, JB, Honko, AN, Sood, V et al. (2010). Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 375: 1896-1905
4. Kumar, P, Ban, H-S, Kim, S-S, Wu, H. Pearson, T, Greiner, DL, et al. (2008). T cellspecific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134: 577-586
5. Morrissey, DV, Lockridge, JA, Shaw, L, Blanchard, K, Jensen, K, Breen, W et al. (2005). Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 23: 1002-1007 (Pubitemid 41114035)
6. Niu, XY, Peng, ZL, Duan, WQ, Wang, H and Wang, P (2006). Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Int J Gynecol Cancer 16: 743-751
7. Okumura, A, Pitha, PM and Harty, RN (2008). ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci USA 105: 3974-3979 (Pubitemid 351723509)
8. Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, Hirai K et al. (2005). Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. PNAS 102: 12177-12182 (Pubitemid 41291148)
9. Huang, YH, Bao, Y, Peng, W, Goldberg, M, Love, K, Bumcrot, DA et al. (2009). Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis. Proc Natl Acad Sci USA 106: 3426-3430
10. Davis, ME, Zuckerman, JE, Choi, CH, Seligson, D, Tolcher, A, Alabi, CA et al. (2010). Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464: 1067-1070
11. Frank-Kamenetsky, M, Grefhorst, A, Anderson, NN, Racie, TS, Bramlage, B, Akinc, A et al. (2008). Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci USA 105: 11915-11920
12. Love, KT, Mahon, KP, Levins, CG, Whitehead, KA, Querbes, W, Dorkin, JR et al. (2010). Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA 107: 1864-1869
13. Sato, Y, Murase, K, Kato, J, Kobune, M, Sato, T, Kawano, Y et al. (2008). Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagenspecific chaperone. Nat Biotechnol 26: 431-442 (Pubitemid 351501817)
14. Wilson, DS, Dalmasso, G, Wang, L, Sitaraman, SV, Merlin, D and Murthy, N (2010). Orally delivered thioketal nanoparticles loaded with TNF-a-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater 9: 923-928
15. Subramanya, S, Armant, M, Salkowitz, JR, Nyakeriga, AM, Haridas, V, Hasan, M et al. (2010). Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA. Mol Ther 18: 2028-2037
16. Goldberg, MS, Xing, D, Ren, Y, Orsulic, S, Bhatia, SN and Sharp, PA (2011). Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells. Proc Natl Acad Sci USA 108: 745-750
17. Deshayes, S, Morris, M, Heitz, F and Divita, G (2008). Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv Drug Deliv Rev 60: 537-547 (Pubitemid 351222678)
18. Akinc, A and Langer, R (2002). Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking. Biotechnol Bioeng 78: 503-508 (Pubitemid 34727946)
19. Whitehead, KA, Langer, R and Anderson, DG (2009). Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 8: 129-138
20. Akinc, A, Zumbuehl, A, Goldberg, M, Leshchiner, ES, Busini, V, Hossain, N et al. (2008). A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 26: 561-569 (Pubitemid 351668042)
21. Rozema, DB, Lewis, DL, Wakefield, DH, Wong, SC, Klein, JJ, Roesch, PL et al. (2007). Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci USA 104: 12982-12987 (Pubitemid 351737577)
22. Wolfrum, C, Shi, S, Jayaprakash, KN, Jayaraman, M, Wang, G, Pandey, RK et al. (2007). Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat Biotechnol 25: 1149-1157 (Pubitemid 47538115)
23. Woodrow, KA, Cu, Y, Booth, CJ, Saucier-Sawyer, JK, Wood, MJ and Saltzman, WM (2009). Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater 8: 526-533
24. Zhang, S, Zhao, B, Jiang, H, Wang, B and Ma, B (2007). Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 123: 1-10 (Pubitemid 47444388)
25. Semple, SC, Akinc, A, Chen, J, Sandhu, AP, Mui, BL, Cho, CK et al. (2010). Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 28: 172-176
26. Han, SE, Kang, H, Shim, GY, Suh, MS, Kim, SJ, Kim, JS et al. (2008). Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA. Int J Pharm 353: 260-269
27. Heyes, J, Palmer, L, Bremner, K and MacLachlan, I (2005). Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J Control Release 107: 276-287 (Pubitemid 41316290)